emg amplifier system Search Results


90
MagVenture inc electromyogram amplifier module
Electromyogram Amplifier Module, supplied by MagVenture inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/electromyogram amplifier module/product/MagVenture inc
Average 90 stars, based on 1 article reviews
electromyogram amplifier module - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Motion Lab Systems Inc surface emg sensors ma-411
Surface Emg Sensors Ma 411, supplied by Motion Lab Systems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/surface emg sensors ma-411/product/Motion Lab Systems Inc
Average 90 stars, based on 1 article reviews
surface emg sensors ma-411 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
BIOPAC amplifier and digitizer emg-r2
Amplifier And Digitizer Emg R2, supplied by BIOPAC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/amplifier and digitizer emg-r2/product/BIOPAC
Average 90 stars, based on 1 article reviews
amplifier and digitizer emg-r2 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Alpha-Omega Engineering eeg/emg activity was amplified (500x), filtered (1 – 100 hz for eeg
Eeg/Emg Activity Was Amplified (500x), Filtered (1 – 100 Hz For Eeg, supplied by Alpha-Omega Engineering, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/eeg/emg activity was amplified (500x), filtered (1 – 100 hz for eeg/product/Alpha-Omega Engineering
Average 90 stars, based on 1 article reviews
eeg/emg activity was amplified (500x), filtered (1 – 100 hz for eeg - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Myotronics Research Inc multi-channel emg amplifier
Multi Channel Emg Amplifier, supplied by Myotronics Research Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/multi-channel emg amplifier/product/Myotronics Research Inc
Average 90 stars, based on 1 article reviews
multi-channel emg amplifier - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Bortec Biomedical Ltd emg signal pre-amplifier and filter
Emg Signal Pre Amplifier And Filter, supplied by Bortec Biomedical Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/emg signal pre-amplifier and filter/product/Bortec Biomedical Ltd
Average 90 stars, based on 1 article reviews
emg signal pre-amplifier and filter - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
BIOPAC surface emg signal amplifier and recorder
Surface Emg Signal Amplifier And Recorder, supplied by BIOPAC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/surface emg signal amplifier and recorder/product/BIOPAC
Average 90 stars, based on 1 article reviews
surface emg signal amplifier and recorder - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Bortec Biomedical Ltd isolated emg amplifiers octopus
Isolated Emg Amplifiers Octopus, supplied by Bortec Biomedical Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/isolated emg amplifiers octopus/product/Bortec Biomedical Ltd
Average 90 stars, based on 1 article reviews
isolated emg amplifiers octopus - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
BIOPAC emg150 amplifiers
Emg150 Amplifiers, supplied by BIOPAC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/emg150 amplifiers/product/BIOPAC
Average 90 stars, based on 1 article reviews
emg150 amplifiers - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Bioelectronica Inc wired electromyography (emg) system at 1000 hz emg usb2
Wired Electromyography (Emg) System At 1000 Hz Emg Usb2, supplied by Bioelectronica Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wired electromyography (emg) system at 1000 hz emg usb2/product/Bioelectronica Inc
Average 90 stars, based on 1 article reviews
wired electromyography (emg) system at 1000 hz emg usb2 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Nihon Kohden corporation meg-6116m
Meg 6116m, supplied by Nihon Kohden corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/meg-6116m/product/Nihon Kohden corporation
Average 90 stars, based on 1 article reviews
meg-6116m - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Pinnacle Technology Inc two eeg channel, two emg channel mouse pre-amplifier
Ablation of Sox14 + IGL/LGv neurons causes delayed vigilance state transitions at circadian light changes. A , B , <t>spectrograms,</t> <t>EEG/EMG</t> traces, and hypnograms over a one-hour period from a representative control mouse and an ablated mouse. C , over a 24-hour period control and Sox14 + IGL/LGv-ablated mice spend a similar percentage of time in Wake (48.24 % ± 1.96 % vs 48.22 % ± 1.71 %, p = 0.99), NREM (46.73 % ± 1.80 % vs 46.38 % ± 1.71 %, p = 0.89) and REM (5.03 % ± 0.20 % vs 5.39 % ± 0.17 %, p = 0.2). Values are mean ± s.e.m., t-test. D , E , distribution of Wake, NREM and REM in the two hours preceding and following each light transition. Light and dark hours are shaded in yellow and grey, respectively (see for comprehensive statistics). F , pairwise comparison in the content of Wake, NREM and REM between the hour preceding and each of the two hours following the light to dark transition. Control group: Wake -1 : 33.17 % ± 2.98 %, Wake 1 : 80.26 % ± 3.49 %, p < 0.0001, Wake 2 : 72.61 % ± 7.76 %, p = 0.001; NREM -1 : 60.08 % ± 2.65 %, NREM 1 : 18.39 % ± 3.29 %, p = 0.0001, NREM 2 : 25.17 % ± 7.04 %, p = 0.0015; REM -1 : 6.75 % ± 0.52 %, REM 1 : 1.35 % ± 0.45 % p = 0.0004, REM 2 : 2.18% ± 0.85 % p = 0.007. Ablated group: Wake -1 36.57 % ± 5.34 %, Wake 1 : 56.67 % ± 3.49 %, p = 0.093, Wake 2 : 75.23 % ± 7.24 %, p = 0.008; NREM -1 56.35 % ± 4.73 %, NREM 1 : 38.19 % ± 7.68 %, p = 0.093, NREM 2 : 22.36 % ± 6.64 %, p = 0.0081; REM -1 : 7.08 % ± 0.78 %, REM 1 : 5.10 % ± 1.16 %, p = 0.296, REM 2 : 2.41 % ± 0.90 %, p = 0.031. Values are mean ± s.e.m., t-test except Control REM -1 versus REM 2 , Ablated REM -1 versus REM 1 and REM 2 Wilcoxon test. G , pairwise comparison in the content of Wake, NREM and REM between the hour preceding and each of the two hours following the dark to light transition. Control group: Wake -1 : 94.77 % ± 3.48 %, Wake 1 : 63.47 % ± 9.42 %, p = 0.015, Wake 2 : 36.11 % ± 9.72 %, p = 0.015; NREM -1 : 5.22 % ± 3.48 %, NREM 1 : 34.87 % ± 8.82 % p = 0.015, NREM 2 : 57.51 % ± 8.86 % p = 0.015; REM -1 : 0.00 % ± 0.00 %, REM 1 : 1.66 % ± 0.64 %, p = 0.125, REM 2 : 6.37 % ± 1.09 %, p = 0.015. Ablated group: Wake -1 79.18 % ± 7.51 %, Wake 1 : 82.47 % ± 7.80 %, p = 0.812, Wake 2 : 39.37 % ± 8.09 %, p = 0.017; NREM -1 20.50 % ± 7.34 %, NREM 1 : 17.25 % ± 7.65 %, p = 0.848, NREM 2 : 56.31 % ± 7.22 %, p = 0.021; REM -1 : 0.31 % ± 0.21 %, REM 1 : 0.27 % ± 0.20 %, p > 0.999, REM 2 : 4.31 % ± 1.34 %, p = 0.0313. Values are mean ± s.e.m., Wilcoxon test except Ablated Wake -1 versus Wake 2 and NREM -1 versus NREM 2 t-test. H , fold change in distance travelled in the light phase (12 hours). Total distance in the dark phase (12 hours) was set at 1. Control group: 1.0 ± 0.14 (dark) versus 0.77 ± 0.26 (light); Ablated group: 1.0 ± 0.17 (dark) versus 0.52 ± 0.82 (light). I , Example trajectories for one control and one ablated mouse in the hour preceding and following the light change. Oval: ROI used for automated tracking; yellow: light, grey: dark. Histograms report the fold change in distance travelled in the hour preceding and following the light change. For the light to dark transition distance in the light was set at 1: Control group 1.0 ± 0.21 (light) 5.59 ± 1.36 (dark), p = 0.0078; Ablated group 1.0 ± 0.17 (light) 2.80 ± 0.68 (dark), p = 0.044. J , For the dark to light transition distance in the dark was set at 1: Control group 1.0 ± 0.15 vs 0.64 ± 0.31, p = 0.148; Ablated group 1.0 ± 0.28 vs 0.92 ± 0.29, p = 0.468. Values are mean ± s.e.m., Wilcoxon test except for Ablated light to dark transition t-test. A summary of statistical tests is available in .
Two Eeg Channel, Two Emg Channel Mouse Pre Amplifier, supplied by Pinnacle Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/two eeg channel, two emg channel mouse pre-amplifier/product/Pinnacle Technology Inc
Average 90 stars, based on 1 article reviews
two eeg channel, two emg channel mouse pre-amplifier - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Ablation of Sox14 + IGL/LGv neurons causes delayed vigilance state transitions at circadian light changes. A , B , spectrograms, EEG/EMG traces, and hypnograms over a one-hour period from a representative control mouse and an ablated mouse. C , over a 24-hour period control and Sox14 + IGL/LGv-ablated mice spend a similar percentage of time in Wake (48.24 % ± 1.96 % vs 48.22 % ± 1.71 %, p = 0.99), NREM (46.73 % ± 1.80 % vs 46.38 % ± 1.71 %, p = 0.89) and REM (5.03 % ± 0.20 % vs 5.39 % ± 0.17 %, p = 0.2). Values are mean ± s.e.m., t-test. D , E , distribution of Wake, NREM and REM in the two hours preceding and following each light transition. Light and dark hours are shaded in yellow and grey, respectively (see for comprehensive statistics). F , pairwise comparison in the content of Wake, NREM and REM between the hour preceding and each of the two hours following the light to dark transition. Control group: Wake -1 : 33.17 % ± 2.98 %, Wake 1 : 80.26 % ± 3.49 %, p < 0.0001, Wake 2 : 72.61 % ± 7.76 %, p = 0.001; NREM -1 : 60.08 % ± 2.65 %, NREM 1 : 18.39 % ± 3.29 %, p = 0.0001, NREM 2 : 25.17 % ± 7.04 %, p = 0.0015; REM -1 : 6.75 % ± 0.52 %, REM 1 : 1.35 % ± 0.45 % p = 0.0004, REM 2 : 2.18% ± 0.85 % p = 0.007. Ablated group: Wake -1 36.57 % ± 5.34 %, Wake 1 : 56.67 % ± 3.49 %, p = 0.093, Wake 2 : 75.23 % ± 7.24 %, p = 0.008; NREM -1 56.35 % ± 4.73 %, NREM 1 : 38.19 % ± 7.68 %, p = 0.093, NREM 2 : 22.36 % ± 6.64 %, p = 0.0081; REM -1 : 7.08 % ± 0.78 %, REM 1 : 5.10 % ± 1.16 %, p = 0.296, REM 2 : 2.41 % ± 0.90 %, p = 0.031. Values are mean ± s.e.m., t-test except Control REM -1 versus REM 2 , Ablated REM -1 versus REM 1 and REM 2 Wilcoxon test. G , pairwise comparison in the content of Wake, NREM and REM between the hour preceding and each of the two hours following the dark to light transition. Control group: Wake -1 : 94.77 % ± 3.48 %, Wake 1 : 63.47 % ± 9.42 %, p = 0.015, Wake 2 : 36.11 % ± 9.72 %, p = 0.015; NREM -1 : 5.22 % ± 3.48 %, NREM 1 : 34.87 % ± 8.82 % p = 0.015, NREM 2 : 57.51 % ± 8.86 % p = 0.015; REM -1 : 0.00 % ± 0.00 %, REM 1 : 1.66 % ± 0.64 %, p = 0.125, REM 2 : 6.37 % ± 1.09 %, p = 0.015. Ablated group: Wake -1 79.18 % ± 7.51 %, Wake 1 : 82.47 % ± 7.80 %, p = 0.812, Wake 2 : 39.37 % ± 8.09 %, p = 0.017; NREM -1 20.50 % ± 7.34 %, NREM 1 : 17.25 % ± 7.65 %, p = 0.848, NREM 2 : 56.31 % ± 7.22 %, p = 0.021; REM -1 : 0.31 % ± 0.21 %, REM 1 : 0.27 % ± 0.20 %, p > 0.999, REM 2 : 4.31 % ± 1.34 %, p = 0.0313. Values are mean ± s.e.m., Wilcoxon test except Ablated Wake -1 versus Wake 2 and NREM -1 versus NREM 2 t-test. H , fold change in distance travelled in the light phase (12 hours). Total distance in the dark phase (12 hours) was set at 1. Control group: 1.0 ± 0.14 (dark) versus 0.77 ± 0.26 (light); Ablated group: 1.0 ± 0.17 (dark) versus 0.52 ± 0.82 (light). I , Example trajectories for one control and one ablated mouse in the hour preceding and following the light change. Oval: ROI used for automated tracking; yellow: light, grey: dark. Histograms report the fold change in distance travelled in the hour preceding and following the light change. For the light to dark transition distance in the light was set at 1: Control group 1.0 ± 0.21 (light) 5.59 ± 1.36 (dark), p = 0.0078; Ablated group 1.0 ± 0.17 (light) 2.80 ± 0.68 (dark), p = 0.044. J , For the dark to light transition distance in the dark was set at 1: Control group 1.0 ± 0.15 vs 0.64 ± 0.31, p = 0.148; Ablated group 1.0 ± 0.28 vs 0.92 ± 0.29, p = 0.468. Values are mean ± s.e.m., Wilcoxon test except for Ablated light to dark transition t-test. A summary of statistical tests is available in .

Journal: bioRxiv

Article Title: A role for thalamic projection GABAergic neurons in circadian responses to light

doi: 10.1101/2022.02.24.481804

Figure Lengend Snippet: Ablation of Sox14 + IGL/LGv neurons causes delayed vigilance state transitions at circadian light changes. A , B , spectrograms, EEG/EMG traces, and hypnograms over a one-hour period from a representative control mouse and an ablated mouse. C , over a 24-hour period control and Sox14 + IGL/LGv-ablated mice spend a similar percentage of time in Wake (48.24 % ± 1.96 % vs 48.22 % ± 1.71 %, p = 0.99), NREM (46.73 % ± 1.80 % vs 46.38 % ± 1.71 %, p = 0.89) and REM (5.03 % ± 0.20 % vs 5.39 % ± 0.17 %, p = 0.2). Values are mean ± s.e.m., t-test. D , E , distribution of Wake, NREM and REM in the two hours preceding and following each light transition. Light and dark hours are shaded in yellow and grey, respectively (see for comprehensive statistics). F , pairwise comparison in the content of Wake, NREM and REM between the hour preceding and each of the two hours following the light to dark transition. Control group: Wake -1 : 33.17 % ± 2.98 %, Wake 1 : 80.26 % ± 3.49 %, p < 0.0001, Wake 2 : 72.61 % ± 7.76 %, p = 0.001; NREM -1 : 60.08 % ± 2.65 %, NREM 1 : 18.39 % ± 3.29 %, p = 0.0001, NREM 2 : 25.17 % ± 7.04 %, p = 0.0015; REM -1 : 6.75 % ± 0.52 %, REM 1 : 1.35 % ± 0.45 % p = 0.0004, REM 2 : 2.18% ± 0.85 % p = 0.007. Ablated group: Wake -1 36.57 % ± 5.34 %, Wake 1 : 56.67 % ± 3.49 %, p = 0.093, Wake 2 : 75.23 % ± 7.24 %, p = 0.008; NREM -1 56.35 % ± 4.73 %, NREM 1 : 38.19 % ± 7.68 %, p = 0.093, NREM 2 : 22.36 % ± 6.64 %, p = 0.0081; REM -1 : 7.08 % ± 0.78 %, REM 1 : 5.10 % ± 1.16 %, p = 0.296, REM 2 : 2.41 % ± 0.90 %, p = 0.031. Values are mean ± s.e.m., t-test except Control REM -1 versus REM 2 , Ablated REM -1 versus REM 1 and REM 2 Wilcoxon test. G , pairwise comparison in the content of Wake, NREM and REM between the hour preceding and each of the two hours following the dark to light transition. Control group: Wake -1 : 94.77 % ± 3.48 %, Wake 1 : 63.47 % ± 9.42 %, p = 0.015, Wake 2 : 36.11 % ± 9.72 %, p = 0.015; NREM -1 : 5.22 % ± 3.48 %, NREM 1 : 34.87 % ± 8.82 % p = 0.015, NREM 2 : 57.51 % ± 8.86 % p = 0.015; REM -1 : 0.00 % ± 0.00 %, REM 1 : 1.66 % ± 0.64 %, p = 0.125, REM 2 : 6.37 % ± 1.09 %, p = 0.015. Ablated group: Wake -1 79.18 % ± 7.51 %, Wake 1 : 82.47 % ± 7.80 %, p = 0.812, Wake 2 : 39.37 % ± 8.09 %, p = 0.017; NREM -1 20.50 % ± 7.34 %, NREM 1 : 17.25 % ± 7.65 %, p = 0.848, NREM 2 : 56.31 % ± 7.22 %, p = 0.021; REM -1 : 0.31 % ± 0.21 %, REM 1 : 0.27 % ± 0.20 %, p > 0.999, REM 2 : 4.31 % ± 1.34 %, p = 0.0313. Values are mean ± s.e.m., Wilcoxon test except Ablated Wake -1 versus Wake 2 and NREM -1 versus NREM 2 t-test. H , fold change in distance travelled in the light phase (12 hours). Total distance in the dark phase (12 hours) was set at 1. Control group: 1.0 ± 0.14 (dark) versus 0.77 ± 0.26 (light); Ablated group: 1.0 ± 0.17 (dark) versus 0.52 ± 0.82 (light). I , Example trajectories for one control and one ablated mouse in the hour preceding and following the light change. Oval: ROI used for automated tracking; yellow: light, grey: dark. Histograms report the fold change in distance travelled in the hour preceding and following the light change. For the light to dark transition distance in the light was set at 1: Control group 1.0 ± 0.21 (light) 5.59 ± 1.36 (dark), p = 0.0078; Ablated group 1.0 ± 0.17 (light) 2.80 ± 0.68 (dark), p = 0.044. J , For the dark to light transition distance in the dark was set at 1: Control group 1.0 ± 0.15 vs 0.64 ± 0.31, p = 0.148; Ablated group 1.0 ± 0.28 vs 0.92 ± 0.29, p = 0.468. Values are mean ± s.e.m., Wilcoxon test except for Ablated light to dark transition t-test. A summary of statistical tests is available in .

Article Snippet: The EEG/EMG signals were sampled at 250 Hz, amplified 100× and low-pass filtered at 100 Hz using a two EEG channel, two EMG channel mouse pre-amplifier (Pinnacle Technology Inc).

Techniques: